Clinical Trial

A Study for HSK44459 in Participants With Atopic Dermatitis

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 2, 2026 (before its estimated January 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess the efficacy and safety of HSK44459 in adults with Atopic Dermatitis
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-21.
Status change: Recruiting → Active, Not Recruiting 2025-12-31
Trial Details
NCT Number NCT06996912
Lead Sponsor Xizang Haisco Pharmaceutical Co., Ltd
Conditions Atopic Dermatitis (AD)
Enrollment 150 participants
Start Date 2025-05-22
Primary Completion 2026-01-20 (estimated)
Study Completion 2026-03-23 (estimated)
Updated on ClinicalTrials.gov 2026-01-02